Advances in Reperfusion Therapy and Cytoprotection for Acute Ischemic Stroke

Area of Science:

• Neurology
• Neuroscience
• Clinical Medicine

Background:

• Stroke is a major global cause of death and disability.
• Acute ischemic stroke (AIS) accounts for 87% of stroke cases.
• Timely reperfusion therapy is the primary treatment for AIS.

Purpose of the Study:

• To review recent advancements in reperfusion therapy for AIS.
• To explore the potential of cytoprotective therapies in managing ischemic and reperfusion injury.
• To identify challenges and future directions in AIS treatment.

Main Methods:

• Literature review of high-quality clinical trials.
• Analysis of studies on reperfusion strategies.
• Evaluation of research on cytoprotective agents and their synergistic effects.

Main Results:

• Significant progress has been made in reperfusion strategies over the last decade.
• Cytoprotective therapies aim to reduce brain damage but have faced clinical trial challenges.
• Past trials offer valuable insights for developing future cytoprotective agents.

Conclusions:

• Reperfusion therapy remains the cornerstone of acute ischemic stroke treatment.
• Cytoprotective therapies hold potential for synergistic benefits with reperfusion.
• Further research is needed to overcome challenges in developing effective cytoprotective agents for AIS.